Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY 4.0Journal of Pharmaceutical Policy and Practice

Effects of pharmacists’ involvement in pharmacogenomics implementation on patient outcomes: a scoping review

6 affiliations
  1. 1Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
  2. 2Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan
  3. 3Department of Medical Education, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
  4. 4College of Nursing, University of Baghdad, Baghdad, Iraq
  5. 5Department of Pharmacy Practice and Pharmacotherapy, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
  6. 6Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

Abstract

Background: Pharmacogenomics holds promise for personalised medicine, but its implementation requires effective integration into clinical workflows. Pharmacists, with their medication expertise, are positioned to play a key role in implementing these services. However, a comprehensive synthesis of evidence regarding pharmacists’ roles in pharmacogenomic implementation has been lacking.

Methods: A scoping review was conducted following a pre-registered protocol and PRISMA-ScR guidance. PubMed/MEDLINE, Scopus, Cochrane Library, CINAHL, and PsycINFO were searched from January 2015 to September 2026, supplemented by grey literature and reference screening. Studies examining pharmacist involvement in clinical PGx implementation were eligible. Data were extracted, critically appraised using design-specific tools, and synthesised thematically.

Results: From an initial yield of 870 records identified through database and grey literature searching, studies were screened, and eligible evidence was synthesised in this scoping review. Included literature comprised cross-sectional (n = 2), quasi-experimental (n = 1), case series (n = 5), qualitative (n = 1), mixed-methods (n = 1), descriptive implementation (n = 3), and an AI-based clinical decision-support evaluation (n = 1). Overall methodological quality was moderate to low, reflecting predominantly observational and implementation-oriented designs. Thematic synthesis identified key domains: pharmacist roles in PGx workflow integration, result interpretation, clinical decision support use, interprofessional collaboration, patient education, medication optimization, implementation leadership, and system-level barriers.

Conclusion: Pharmacists are central to successful PGx implementation across diverse healthcare settings. Although evidence supports improvements in implementation processes and prescribing decisions, robust evidence demonstrating long-term clinical and economic benefits remains limited. Future research should prioritise rigorous outcome-focused evaluations to support sustainable integration of pharmacist-led PGx services.

Related

  1. Electronic collection of medication adherence patient-reported outcomes data in community pharmacies: Pilot implementation outcomes
    Margie E. Snyder, Katelyn N. Hettinger-Riddell, Bonyan Qudah +12
    Journal of the American Pharmacists Association : JAPhAPeer-reviewedLicence not statedFull textGeneral medicinePMC
  2. Implementation of Pharmacogenomics in Pediatric-Focused Institutions Within the Pharmacogenomics Global Research Network.
    Laura B Ramsey, Chad Bousman, Rebecca Brand +13
    Clinical pharmacology and therapeuticsPeer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMCPMC
  3. Anticancer Drugs Pharmacogenomics in African Populations: A Scoping Review of Clinico-Molecular Data and Involvement in Personalized Medicine
    Marc Donald Wilfried Adico, Tata Gnire Safiatou Coulibaly, Dramane Dagnogo +10
    Pharmacogenomics and Personalized MedicinePeer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyPMC
  4. Defining Core Functions and Forms for the Implementation of Pharmacogenomics Testing in Primary Care
    Sanjana Ramesh, Larisa H. Cavallari, Victoria Wittner +14
    Clinical and Translational SciencePeer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyPMC
  5. Impact of Early Interprofessional Involvement with a Critical Care Pharmacist on Patient Outcomes in the Intensive Care Unit
    K. Henry, B. A. Smith, D. N. Holden +10
    medRxivPreprintCC BY-NCFull text1 citedEpidemiology & public healthmedRxiv
BibTeX
@article{mazrouei2026effects,
  title = {{Effects of pharmacists’ involvement in pharmacogenomics implementation on patient outcomes: a scoping review}},
  author = {Nadia Al Mazrouei and Khalid Awad Al-Kubaisi and Karem H. Alzoubi and Ahmed Alhusban and Richard Mottershead and Moh'D. Ahmad Shara and Manal Mohammed Al Sharawy and Margaret Stevenson},
  journal = {Journal of Pharmaceutical Policy and Practice},
  year = {2026},
  month = nov,
  doi = {10.1080/20523211.2026.2746884},
  url = {https://doi.org/10.1080/20523211.2026.2746884},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Effects of pharmacists’ involvement in pharmacogenomics implementation on patient outcomes: a scoping review
AU  - Nadia Al Mazrouei
AU  - Khalid Awad Al-Kubaisi
AU  - Karem H. Alzoubi
AU  - Ahmed Alhusban
AU  - Richard Mottershead
AU  - Moh'D. Ahmad Shara
AU  - Manal Mohammed Al Sharawy
AU  - Margaret Stevenson
PY  - 2026
DA  - 2026/11/03
JO  - Journal of Pharmaceutical Policy and Practice
DO  - 10.1080/20523211.2026.2746884
UR  - https://doi.org/10.1080/20523211.2026.2746884
AB  - Background: Pharmacogenomics holds promise for personalised medicine, but its implementation requires effective integration into clinical workflows. Pharmacists, with their medication expertise, are positioned to play a key role in implementing these services. However, a comprehensive synthesis of evidence regarding pharmacists’ roles in pharmacogenomic implementation has been lacking.  Methods: A scoping review was conducted following a pre-registered protocol and PRISMA-ScR guidance. PubMed/MEDLINE, Scopus, Cochrane Library, CINAHL, and PsycINFO were searched from January 2015 to September 2026, supplemented by grey literature and reference screening. Studies examining pharmacist involvement in clinical PGx implementation were eligible. Data were extracted, critically appraised using design-specific tools, and synthesised thematically.  Results: From an initial yield of 870 records identified through database and grey literature searching, studies were screened, and eligible evidence was synthesised in this scoping review. Included literature comprised cross-sectional (n = 2), quasi-experimental (n = 1), case series (n = 5), qualitative (n = 1), mixed-methods (n = 1), descriptive implementation (n = 3), and an AI-based clinical decision-support evaluation (n = 1). Overall methodological quality was moderate to low, reflecting predominantly observational and implementation-oriented designs. Thematic synthesis identified key domains: pharmacist roles in PGx workflow integration, result interpretation, clinical decision support use, interprofessional collaboration, patient education, medication optimization, implementation leadership, and system-level barriers.  Conclusion: Pharmacists are central to successful PGx implementation across diverse healthcare settings. Although evidence supports improvements in implementation processes and prescribing decisions, robust evidence demonstrating long-term clinical and economic benefits remains limited. Future research should prioritise rigorous outcome-focused evaluations to support sustainable integration of pharmacist-led PGx services.
SN  - 2052-3211
ER  -